세계의 합성생물학(신바이오) 시장(2026-2036년)

The global synthetic biology market represents one of the most transformative and rapidly expanding sectors in modern biotechnology, fundamentally reshaping how we approach medicine, agriculture, manufacturing, and environmental challenges. Valued at approximately $16-18 billion in 2024, the market is projected to experience explosive growth, driven by advances in genetic engineering, computational design, and automated biological systems.

The synthetic biology market is experiencing robust growth at a compound annual growth rate (CAGR) of 20.6-28.63%, fueled by several converging factors. The dramatic reduction in DNA sequencing and synthesis costs has democratized access to genetic engineering tools, while artificial intelligence and machine learning algorithms have accelerated the design of biological systems. Rising demand for bio-based products, growing demand for personalized therapies, and advancements in DNA sequencing and synthesis technologies are key factors accelerating market growth.

The pharmaceutical and healthcare sector dominates the market landscape. This dominance stems from synthetic biology's impact on drug discovery, personalized medicine, and therapeutic development. The technology enables the creation of novel biologics, synthetic vaccines, and engineered cell therapies that address previously untreatable conditions.

Despite remarkable growth prospects, the synthetic biology market faces several challenges. Regulatory uncertainty remains a significant barrier, as existing frameworks struggle to keep pace with rapid technological advancement. Public acceptance and ethical concerns surrounding genetic engineering applications require ongoing attention and transparent communication about benefits and risks. Technical challenges include scaling laboratory innovations to industrial production, ensuring reliability and predictability of engineered biological systems, and developing standardized tools and methodologies. The complexity of biological systems continues to present engineering challenges that require sustained research and development investment.

The synthetic biology market represents a paradigm shift toward programmable biology, where engineered biological systems address global challenges in healthcare, food security, climate change, and sustainable manufacturing. As the technology matures and costs continue to decline, synthetic biology is poised to become a cornerstone of the 21st-century bioeconomy, creating unprecedented opportunities for innovation and economic growth while addressing humanity's most pressing challenges.

"The Global Synthetic Biology (Synbio) Market 2026-2036" represents the most comprehensive analysis of one of biotechnology's fastest-growing sectors, providing essential intelligence for investors, industry leaders, and strategic planners. This definitive market report delivers critical insights into the transformative synthetic biology landscape, covering market dynamics, technological innovations, competitive positioning, and growth opportunities across key application areas including pharmaceuticals, agriculture, industrial biotechnology, and environmental solutions.

Report contents include:

• Technology-based revenue projections
• Product type market dynamics (oligonucleotides, enzymes, synthetic genes, synthetic cells)
• Regional market opportunities across North America, Europe, Asia-Pacific, and emerging markets
• Application-specific growth drivers spanning 13 major industry verticals
• Advanced biomanufacturing analysis encompasses:
  • Batch versus continuous bioprocessing optimization
  • Cell-free synthesis systems and scalability challenges
  • Fermentation process innovations and efficiency improvements
  • Biofilm-based production and microfluidic manufacturing systems
  • Photobioreactor technologies and membrane bioreactor applications
• Markets & Applications:
  • Biofuels & Energy: Bioethanol, biodiesel, biogas, renewable diesel, biojet fuel, and hydrogen production
  • Bio-based Chemicals: Industrial chemicals, specialty chemicals, and sustainable chemical manufacturing
  • Bioplastics & Biopolymers: PLA, PHA, bio-PET, and next-generation biodegradable materials
  • Healthcare & Pharmaceuticals: Drug discovery, gene therapy, vaccine production, personalized medicine
  • Agriculture & Food: Crop enhancement, biofertilizers, biopesticides, alternative proteins
  • Textiles & Materials: Bio-based fibers, sustainable leather alternatives, mycelium materials
  • Environmental Solutions: Bioremediation, carbon capture, pollution control technologies
• Regional Market Analysis & Growth Opportunities
• Competitive Landscape & Company Profiles. The report features comprehensive profiles of 320+ leading synthetic biology companies, providing detailed analysis of business models, product portfolios, financial performance, and strategic positioning. Our competitive intelligence covers established biotechnology leaders, emerging startups, and technology platform providers across the synthetic biology value chain. Companies profiled include Aanika Biosciences, Aemetis Inc., AEP Polymers, Afyren, AgBiome, AgriSea NZ Seaweed Ltd, Agrivida, Ainnocence, AIO, AI Proteins, Algal Bio Co. Ltd., Algenol, AlgiKnit, Algiecel ApS, Alpha Biofuels Singapore Pte Ltd, Allonnia LLC, Allozymes, Alt.Leather, Alto Neuroscience, Amano Enzyme Inc., AmphiStar, Amply Discovery, AMSilk GmbH, Amyris, Andes Ag Inc., Ansa Biotechnologies, Antheia, Apeel Sciences, Aralez Bio, Arctic Biomaterials Oy, Ardra Bio, Arkeon, Arsenale Bioyards, Arzeda, Asimov, Atantares, Autolus, AVA Biochem AG, Avantium B.V., Azolla, Axcelon Biopolymers Corporation, Basecamp Research, BBCA Biochemical & GALACTIC Lactic Acid Co. Ltd., Benefuel Inc., BioBetter, Bioextrax AB, Bio Fab NZ, Biokemik, BIOLO, Biomason Inc., Biomemory, Bioplastech Ltd, BioSmart Nano, Biotic Circular Technologies Ltd., Biosyntia, Biotecam, Bioweg, bit.bio, Bloom Biorenewables SA, BluCon Biotech GmbH, Blue BioFuels Inc., Bluepha Beijing Lanjing Microbiology Technology Co. Ltd., Bon Vivant, Bolt Threads, Bosk Bioproducts Inc., Bowil Biotech Sp. z o.o., Braskem SA, Brightseed, Bucha Bio Inc., C1 Green Chemicals AG, C16 Biosciences, CABIO Biotech Wuhan Co Ltd, California Cultured, Calysta, Camena Bioscience, Capra Biosciences, Carbios, Cargill, Calyxt, Cascade Biocatalysts, Cass Materials Pty Ltd, Catalyxx, Cathy Biotech Inc., Cauldron Ferm, Cemvita Factory Inc., ChainCraft, Checkerspot, Chitose Bio Evolution Pte Ltd., CinderBio, Circe, CJ Biomaterials Inc., Clean Food Group, Codagenix, Codexis, Colossal Biosciences, Colipi, Colorifix, Conagen, Constructive Bio, Cysbio, Danimer Scientific, Debut Biotechnology, Deep Branch Biotechnology, Demetrix, Dispersa, DMC Biotechnologies, DNA Script, Domsjo Fabriker AB, DoriNano, DuPont, Earli, Ecovative Design LLC, Eco Fuel Technology Inc, Eden Brew, EggPlant Srl, Eligo Bioscience, Elo Life Systems, Emerging Fuels Technology EFT, Enduro Genetics, EnginZyme AB, Eni S.p.A., EnPlusOne Biosciences, Enzymaster, Enzymit, Erebagen, Esphera SynBio, Euglena Co. Ltd., Eversyn, Evozyne, FabricNano, Fermentalg, eniferBio, ENOUGH, Epoch Biodesign, Evolved By Nature, Evonetix Limited, Evonik Industries AG, EV Biotech, Farmless, Fermelanta and more......
• Investment Analysis & Market Forecasts: insights into funding trends, valuation metrics, and growth opportunities across synthetic biology segments. The report examines venture capital flows, public market performance, and strategic acquisition activity, delivering essential intelligence for investment decision-making.
• Market sizing and growth projections through 2036
• Technology readiness levels and commercialization timelines
• Risk assessment and regulatory consideration
• Strategic partnership opportunities and M&A activity
• Technology Roadmap & Future Outlook
• Future market outlook:
  • Emerging applications in space biotechnology and climate engineering
  • Convergence with artificial intelligence and nanotechnology
  • Regulatory evolution and standardization frameworks
  • Global market expansion and democratization trends

This essential market intelligence report serves as the definitive guide for understanding synthetic biology's transformative potential, providing actionable insights for strategic planning, investment decisions, and market positioning in one of biotechnology's most dynamic sectors.

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

• 1.1. Overview of the global synthetic biology market
• 1.2. Difference between synthetic biology and genetic engineering
• 1.3. Market size and growth projections
  • 1.3.1. By Technology
  • 1.3.2. By Product Type
  • 1.3.3. By Market
  • 1.3.4. By Region
• 1.4. Major trends and drivers
• 1.5. Investments in synthetic biology
• 1.6. Technology roadmap
• 1.7. Industrial biotechnology value chain

2. INTRODUCTION

• 2.1. What is synthetic biology?
• 2.2. Comparison with conventional processes
• 2.3. Applications
• 2.4. Advantages
• 2.5. Sustainability
• 2.6. Synthetic Biology for the Circular Economy

3. TECHNOLOGY ANALYSIS

• 3.1. Biomanufacturing processes
  • 3.1.1. Batch biomanufacturing
  • 3.1.2. Continuous biomanufacturing
  • 3.1.3. Fermentation Processes
  • 3.1.4. Cell-free synthesis
  • 3.1.5. Biofilm-based production
  • 3.1.6. Microfluidic systems
  • 3.1.7. Photobioreactors
  • 3.1.8. Membrane bioreactors
  • 3.1.9. Plant cell culture
  • 3.1.10. Mammalian cell culture
  • 3.1.11. Bioprinting
• 3.2. Cell factories for biomanufacturing
• 3.3. Technology Overview
  • 3.3.1. Metabolic engineering
  • 3.3.2. Gene and DNA synthesis
  • 3.3.3. Gene Synthesis and Assembly
  • 3.3.4. Genome engineering
    • 3.3.4.1. CRISPR
      • 3.3.4.1.1. CRISPR/Cas9-modified biosynthetic pathways
      • 3.3.4.1.2. TALENs
      • 3.3.4.1.3. ZFNs
  • 3.3.5. Protein/Enzyme Engineering
  • 3.3.6. Synthetic genomics
    • 3.3.6.1. Principles of Synthetic Genomics
    • 3.3.6.2. Synthetic Chromosomes and Genomes
  • 3.3.7. Strain construction and optimization
  • 3.3.8. Smart bioprocessing
  • 3.3.9. Chassis organisms
  • 3.3.10. Biomimetics
  • 3.3.11. Sustainable materials
  • 3.3.12. Robotics and automation
    • 3.3.12.1. Robotic cloud laboratories
    • 3.3.12.2. Automating organism design
    • 3.3.12.3. Artificial intelligence and machine learning
  • 3.3.13. Bioinformatics and computational tools
    • 3.3.13.1. Role of Bioinformatics in Synthetic Biology
    • 3.3.13.2. Computational Tools for Design and Analysis
  • 3.3.14. Xenobiology and expanded genetic alphabets
  • 3.3.15. Biosensors and bioelectronics
  • 3.3.16. Feedstocks
    • 3.3.16.1. C1 feedstocks
      • 3.3.16.1.1. Advantages
      • 3.3.16.1.2. Pathways
      • 3.3.16.1.3. Challenges
      • 3.3.16.1.4. Non-methane C1 feedstocks
      • 3.3.16.1.5. Gas fermentation
    • 3.3.16.2. C2 feedstocks
    • 3.3.16.3. Biological conversion of CO2
    • 3.3.16.4. Food processing wastes
    • 3.3.16.5. Lignocellulosic biomass
    • 3.3.16.6. Syngas
    • 3.3.16.7. Glycerol
    • 3.3.16.8. Methane
    • 3.3.16.9. Municipal solid wastes
    • 3.3.16.10. Plastic wastes
    • 3.3.16.11. Plant oils
    • 3.3.16.12. Starch
    • 3.3.16.13. Sugars
    • 3.3.16.14. Used cooking oils
    • 3.3.16.15. Green hydrogen production
    • 3.3.16.16. Blue hydrogen production
  • 3.3.17. Marine biotechnology
    • 3.3.17.1. Cyanobacteria
    • 3.3.17.2. Macroalgae
    • 3.3.17.3. Companies

4. MARKET ANALYSIS

• 4.1. Market trends and drivers
• 4.2. Industry challenges and constraints
• 4.3. Synthetic biology in the bioeconomy
• 4.4. SWOT analysis
• 4.5. Synthetic biology markets
  • 4.5.1. Biofuels
    • 4.5.1.1. Solid Biofuels
    • 4.5.1.2. Liquid Biofuels
    • 4.5.1.3. Gaseous Biofuels
    • 4.5.1.4. Conventional Biofuels
    • 4.5.1.5. Advanced Biofuels
    • 4.5.1.6. Feedstocks
      • 4.5.1.6.1. First-generation (1-G)
      • 4.5.1.6.2. Second-generation (2-G)
        • 4.5.1.6.2.1. Lignocellulosic wastes and residues
        • 4.5.1.6.2.2. Biorefinery lignin
      • 4.5.1.6.3. Third-generation (3-G)
        • 4.5.1.6.3.1. Algal biofuels
          • 4.5.1.6.3.1.1. Properties
          • 4.5.1.6.3.1.2. Advantages
      • 4.5.1.6.4. Fourth-generation (4-G)
      • 4.5.1.6.5. Energy crops
      • 4.5.1.6.6. Agricultural residues
      • 4.5.1.6.7. Manure, sewage sludge and organic waste
      • 4.5.1.6.8. Forestry and wood waste
      • 4.5.1.6.9. Feedstock costs
    • 4.5.1.7. Synthetic biology approaches for biofuel production
    • 4.5.1.8. Bioethanol
      • 4.5.1.8.1. Ethanol to jet fuel technology
      • 4.5.1.8.2. Methanol from pulp & paper production
      • 4.5.1.8.3. Sulfite spent liquor fermentation
      • 4.5.1.8.4. Gasification
        • 4.5.1.8.4.1. Biomass gasification and syngas fermentation
        • 4.5.1.8.4.2. Biomass gasification and syngas thermochemical conversion
      • 4.5.1.8.5. CO2 capture and alcohol synthesis
      • 4.5.1.8.6. Biomass hydrolysis and fermentation
      • 4.5.1.8.7. Separate hydrolysis and fermentation
        • 4.5.1.8.7.1. Simultaneous saccharification and fermentation (SSF)
        • 4.5.1.8.7.2. Pre-hydrolysis and simultaneous saccharification and fermentation (PSSF)
        • 4.5.1.8.7.3. Simultaneous saccharification and co-fermentation (SSCF)
        • 4.5.1.8.7.4. Direct conversion (consolidated bioprocessing) (CBP)
    • 4.5.1.9. Biodiesel
    • 4.5.1.10. Biogas
      • 4.5.1.10.1. Biomethane
      • 4.5.1.10.2. Feedstocks
      • 4.5.1.10.3. Anaerobic digestion
    • 4.5.1.11. Renewable diesel
    • 4.5.1.12. Biojet fuel
    • 4.5.1.13. Algal biofuels (blue biotech)
      • 4.5.1.13.1. Conversion pathways
      • 4.5.1.13.2. Market challenges
      • 4.5.1.13.3. Prices
      • 4.5.1.13.4. Producers
    • 4.5.1.14. Biohydrogen
      • 4.5.1.14.1. Biological Conversion Routes
        • 4.5.1.14.1.1. Bio-photochemical Reaction
        • 4.5.1.14.1.2. Fermentation and Anaerobic Digestion
    • 4.5.1.15. Biobutanol
    • 4.5.1.16. Bio-based methanol
      • 4.5.1.16.1. Anaerobic digestion
      • 4.5.1.16.2. Biomass gasification
      • 4.5.1.16.3. Power to Methane
    • 4.5.1.17. Bioisoprene
    • 4.5.1.18. Fatty Acid Esters
  • 4.5.2. Bio-based chemicals
    • 4.5.2.1. Acetic acid
    • 4.5.2.2. Adipic acid
    • 4.5.2.3. Aldehydes
    • 4.5.2.4. Acrylic acid
    • 4.5.2.5. Bacterial cellulose
    • 4.5.2.6. 1,4-Butanediol (BDO)
    • 4.5.2.7. Bio-DME
    • 4.5.2.8. Dodecanedioic acid (DDDA)
    • 4.5.2.9. Ethylene
    • 4.5.2.10. 3-Hydroxypropionic acid (3-HP)
    • 4.5.2.11. 1,3-Propanediol (1,3-PDO)
    • 4.5.2.12. Itaconic acid
    • 4.5.2.13. Lactic acid (D-LA)
    • 4.5.2.14. 1,5-diaminopentane (DA5)
    • 4.5.2.15. Tetrahydrofuran (THF)
    • 4.5.2.16. Malonic acid
    • 4.5.2.17. Monoethylene glycol (MEG)
    • 4.5.2.18. Propylene
    • 4.5.2.19. Succinic acid (SA)
    • 4.5.2.20. Triglycerides
    • 4.5.2.21. Enzymes
    • 4.5.2.22. Vitamins
    • 4.5.2.23. Antibiotics
  • 4.5.3. Bioplastics and Biopolymers
    • 4.5.3.1. Polylactic acid (PLA)
    • 4.5.3.2. PHAs
      • 4.5.3.2.1. Types
        • 4.5.3.2.1.1. PHB
        • 4.5.3.2.1.2. PHBV
      • 4.5.3.2.2. Synthesis and production processes
      • 4.5.3.2.3. Commercially available PHAs
    • 4.5.3.3. Bio-PET
    • 4.5.3.4. Starch blends
    • 4.5.3.5. Protein-based bioplastics
  • 4.5.4. Bioremediation
  • 4.5.5. Biocatalysis
    • 4.5.5.1. Biotransformations
    • 4.5.5.2. Cascade biocatalysis
    • 4.5.5.3. Co-factor recycling
    • 4.5.5.4. Immobilization
  • 4.5.6. Food and Nutraceutical Ingredients
    • 4.5.6.1. Alternative Proteins
    • 4.5.6.2. Natural Sweeteners
    • 4.5.6.3. Natural Flavors and Fragrances
    • 4.5.6.4. Texturants and Thickeners
    • 4.5.6.5. Nutraceuticals and Supplements
  • 4.5.7. Sustainable agriculture
    • 4.5.7.1. Crop Improvement and Trait Development
    • 4.5.7.2. Plant-Microbe Interactions and Symbiosis
    • 4.5.7.3. Biofertilizers
      • 4.5.7.3.1. Overview
      • 4.5.7.3.2. Companies
    • 4.5.7.4. Biopesticides
      • 4.5.7.4.1. Overview
      • 4.5.7.4.2. Companies
    • 4.5.7.5. Biostimulants
      • 4.5.7.5.1. Overview
      • 4.5.7.5.2. Companies
    • 4.5.7.6. Crop Biotechnology
      • 4.5.7.6.1. Genetic engineering
      • 4.5.7.6.2. Genome editing
      • 4.5.7.6.3. Companies
  • 4.5.8. Textiles
    • 4.5.8.1. Bio-Based Fibers
      • 4.5.8.1.1. Lyocell
      • 4.5.8.1.2. Bacterial cellulose
      • 4.5.8.1.3. Algae textiles
    • 4.5.8.2. Bio-based leather
      • 4.5.8.2.1. Properties of bio-based leathers
        • 4.5.8.2.1.1. Tear strength
        • 4.5.8.2.1.2. Tensile strength
        • 4.5.8.2.1.3. Bally flexing
      • 4.5.8.2.2. Comparison with conventional leathers
      • 4.5.8.2.3. Comparative analysis of bio-based leathers
    • 4.5.8.3. Plant-based leather
      • 4.5.8.3.1. Overview
      • 4.5.8.3.2. Production processes
        • 4.5.8.3.2.1. Feedstocks
        • 4.5.8.3.2.2. Agriculture Residues
        • 4.5.8.3.2.3. Food Processing Waste
        • 4.5.8.3.2.4. Invasive Plants
        • 4.5.8.3.2.5. Culture-Grown Inputs
        • 4.5.8.3.2.6. Textile-Based
        • 4.5.8.3.2.7. Bio-Composite
      • 4.5.8.3.3. Products
      • 4.5.8.3.4. Market players
    • 4.5.8.4. Mycelium leather
      • 4.5.8.4.1. Overview
      • 4.5.8.4.2. Production process
        • 4.5.8.4.2.1. Growth conditions
        • 4.5.8.4.2.2. Tanning Mycelium Leather
        • 4.5.8.4.2.3. Dyeing Mycelium Leather
      • 4.5.8.4.3. Products
      • 4.5.8.4.4. Market players
    • 4.5.8.5. Microbial leather
      • 4.5.8.5.1. Overview
      • 4.5.8.5.2. Production process
      • 4.5.8.5.3. Fermentation conditions
      • 4.5.8.5.4. Harvesting
      • 4.5.8.5.5. Products
      • 4.5.8.5.6. Market players
    • 4.5.8.6. Lab grown leather
      • 4.5.8.6.1. Overview
      • 4.5.8.6.2. Production process
      • 4.5.8.6.3. Products
      • 4.5.8.6.4. Market players
    • 4.5.8.7. Protein-based leather
      • 4.5.8.7.1. Overview
      • 4.5.8.7.2. Production process
      • 4.5.8.7.3. Commercial activity
    • 4.5.8.8. Recombinant Materials
    • 4.5.8.9. Sustainable Processing
  • 4.5.9. Packaging
    • 4.5.9.1. Polyhydroxyalkanoates (PHA)
    • 4.5.9.2. Applications
      • 4.5.9.2.1. Vials, bottles, and containers
      • 4.5.9.2.2. Disposable items and household goods
      • 4.5.9.2.3. Food packaging
      • 4.5.9.2.4. Wet wipes and diapers
    • 4.5.9.3. Proteins
    • 4.5.9.4. Algae-based
    • 4.5.9.5. Mycelium
    • 4.5.9.6. Antimicrobial films and agents
  • 4.5.10. Healthcare and Pharmaceuticals
    • 4.5.10.1. Drug discovery and development
    • 4.5.10.2. Gene therapy and regenerative medicine
    • 4.5.10.3. Vaccine production
    • 4.5.10.4. Personalized medicine
    • 4.5.10.5. Diagnostic tools and biosensors
    • 4.5.10.6. Companies
  • 4.5.11. Cosmetics
  • 4.5.12. Surfactants and detergents
  • 4.5.13. Construction materials
    • 4.5.13.1. Bioconcrete
    • 4.5.13.2. Microalgae biocement
    • 4.5.13.3. Mycelium materials
• 4.6. Global market revenues 2018-2036
  • 4.6.1. By Technology
  • 4.6.2. By Product Type
  • 4.6.3. By Market
  • 4.6.4. By Region
• 4.7. Future Market Outlook

5. COMPANY PROFILES (321 company profiles)

6. APPENDIX

• 6.1. Research Methodology
• 6.2. Glossary of Terms

7. REFERENCES